featured
Discordance in PIK3CA Mutational Status Between Primary and Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis
Breast Cancer Res Treat 2023 Sep 01;201(2)161-169, J Rosin, E Svegrup, A Valachis, I ZerdesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.